Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,910 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-Dimensional MXene (Ti3C2)-Integrated Cellulose Hydrogels: Toward Smart Three-Dimensional Network Nanoplatforms Exhibiting Light-Induced Swelling and Bimodal Photothermal/Chemotherapy Anticancer Activity.
Xing C, Chen S, Liang X, Liu Q, Qu M, Zou Q, Li J, Tan H, Liu L, Fan D, Zhang H. Xing C, et al. Among authors: zou q. ACS Appl Mater Interfaces. 2018 Aug 22;10(33):27631-27643. doi: 10.1021/acsami.8b08314. Epub 2018 Aug 13. ACS Appl Mater Interfaces. 2018. PMID: 30058793
Prodrug-Loaded Zirconium Carbide Nanosheets as a Novel Biophotonic Nanoplatform for Effective Treatment of Cancer.
Liu Q, Xie Z, Qiu M, Shim I, Yang Y, Xie S, Yang Q, Wang D, Chen S, Fan T, Ding B, Guo Z, Adah D, Yao X, Zhang Y, Wu H, Wu Z, Wei C, Wang H, Kim HS, Zou Q, Yan Q, Cai Z, Kim JS, Liu LP, Zhang H, Cao Y. Liu Q, et al. Among authors: zou q. Adv Sci (Weinh). 2020 Nov 5;7(24):2001191. doi: 10.1002/advs.202001191. eCollection 2020 Dec. Adv Sci (Weinh). 2020. PMID: 33344115 Free PMC article.
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Yan XQ, Ye MJ, Zou Q, Chen P, He ZS, Wu B, He DL, He CH, Xue XY, Ji ZG, Chen H, Zhang S, Liu YP, Zhang XD, Fu C, Xu DF, Qiu MX, Lv JJ, Huang J, Ren XB, Cheng Y, Qin WJ, Zhang X, Zhou FJ, Ma LL, Guo JM, Ding DG, Wei SZ, He Y, Guo HQ, Shi BK, Liu L, Liu F, Hu ZQ, Jin XM, Yang L, Zhu SX, Liu JH, Huang YH, Xu T, Liu B, Sun T, Wang ZJ, Jiang HW, Yu DX, Zhou AP, Jiang J, Luan GD, Jin CL, Xu J, Hu JX, Huang YR, Guo J, Zhai W, Sheng XN. Yan XQ, et al. Among authors: zou q. Ann Oncol. 2024 Feb;35(2):190-199. doi: 10.1016/j.annonc.2023.09.3108. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37872020 Free article. Clinical Trial.
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate-To-Severe Disease Activity - A Multicenter Cohort Study of Treatment Strategies and Outcomes.
Deng Y, Qiao L, Li H, Yu C, Jin S, Wang J, Zou Q, Wu L, Duan X, Xu J, Mo H, Jiang Z, Jiang N, Wang Y, Zeng X, Li M, Wang Q, Tian X; CREDIT Co‐authors. Deng Y, et al. Among authors: zou q. Int J Rheum Dis. 2025 Jan;28(1):e70066. doi: 10.1111/1756-185X.70066. Int J Rheum Dis. 2025. PMID: 39825583
2,910 results